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Summary The potential long-term toxicity of central nervous system prophylaxis (CNS-P) in adult acute
lymphoblastic leukaemia (ALL, n = 17) and non-Hodgkin's lymphoma (NHL, n = 7) was investigated in a
multidisciplinary study. At least 4 years had elapsed from CNS-P (mean 11.5 years) for all patients.
Neurological history and physical examination were unremarkable; minor signs were commoner in older
patients (P< 0.02). Psychometry yielded normal results, but individual verbal IQ generally exceeded perfor-
mance IQ, with a trend to more marked differences in younger adults (P = 0.06). EEG was scored and differed
significantly from that of controls, with a tendency to more marked (but still minor) abnormalities in younger
patients (P = 0.06). Brainstem auditory evoked potentials demonstrated significant but generally minor abnor-
mality in 24% of patients. CT brain scan revealed widening of cerebral hemisphere sulci to >3 mm in 38% of
patients; cerebral atrophy was commoner in the older group (P< 0.02) and those with neurological signs
(P<0.02). MRI brain scans were normal in all patients tested. Thus, following standard CNS-P for ALL at
this hospital, there is a 5% primary CNS relapse rate, and only minimal, mainly subclinical, long-term
neuropsychological toxicity.
An important aspect of the 'total therapy' concept for treat-
ment of childhood acute lymphoblastic leukaemia (ALL) is
the specific prophylactic treatment of the central nervous
system (CNS-P) (Aur et al., 1971; Report to the Medical
Research Council, 1973). The combination of external cranial
irradiation to 24 Gy with five doses of intrathecal metho-
trexate has reduced the primary CNS relapse rate from about
75% to 10% or less. In the late 1970s reports emerged
indicating that long-term survivors of childhood ALL
appeared to have subnormal IQ, typically presenting with
learning difficulties (Meadows et al., 1981; Eiser et al., 1978;
Moss et al., 1981; Carli et al., 1985). It is now apparent that
long-term CNS problems may range in severity from minor
intellectual dysfunction to severe neuropsychological damage,
seizures and dementia (Bleyer, 1981).
As ALL is less common in adults than in children, the
former have received less attention regarding the potential
neurotoxicity of CNS-P. Intensive therapy of adult ALL may
now yield survival figures approaching those for children
(Linker et al., 1987; Omura et al., 1980). It is therefore
increasingly important to look for possible long-term adverse
effects of therapy. To our knowledge there are no published
data addressing this issue. The results of a multidisciplinary
investigation of adults with ALL and NHL who received
standard CNS-P are presented.
Materials and methods
Patients
Acute tymphoblastic leukaemia Between 1972 and 1982, 112
consecutive, previously untreated adults aged 15-69 years
were referred to the ICRF department of Medical Oncology
at St Bartholomew's Hospital for treatment of ALL. Full
details of these patients, their treatment and outcome have
been published (Barnett et al., 1986). Briefly, induction
therapy consisted of four cycles of OPAL (vincristine, predni-
solone and adriamycin with L-asparaginase in the first cycle
only) for the first 63 patients; the subsequent 49 patients
received six cycles, with escalating doses of adriamycin and
cyclophosphamide from cycle 3 (HEAV'D). Provided com-
plete remission (CR) was achieved, maintenance chemo-
therapy with 6-mercaptopurine, methotrexate and cyclophos-
phamide was begun, and continued for 3 years or till relapse.
Early central nervous system prophylaxis comprised intra-
thecal chemotherapy and cranial irradiation. Following the
planned four or six cycles of induction therapy, 24 Gy mid-
plane dose was delivered to the cranium in 12 fractions over
17-21 days. As meningeal infiltration may occur early in
adult ALL (Lister et al., 1977) it became the policy to give
intrathecal (i.t.) methotrexate 12.5 mg as soon as possible
after clearing of blast cells from the peripheral blood, with
each subsequent cycle of induction treatment, and twice
weekly during the course of radiotherapy. It. cytosine arab-
inoside was introduced early as a substitute for methotrexate
if there was intolerance to the latter. The plan was to give
five i.t. injections of each; 3/17 patients actually received this
and modifications were often necessary. Thus between zero
and seven (median five) doses of i.t. methotrexate were given,
and between zero and five (median none) doses of i.t.
cytosine arabinoside.
Twenty-five patients treated as described above were alive
in 1986, of whom 17 agreed to participate in the study. Five
patients refused to be studied, two patients had moved away,
and one patient with a prior intracranial haemorrhage was
excluded. Their characteristics are summarised in Table I.
Fourteen patients were in continuous first CR; three were in
unmaintained second CR after an isolated extramedullary
relapse. One of the extramedullary relapses occurred in the
CNS, the other two were testicular. The former patient re-
mains in prolonged second CR following five i.t. injections of
cytosine arabinoside, 3 years of maintenance chemotherapy
and finally craniospinal radiotherapy (24Gy to cranium,
20 Gy to spine). The other two patients were treated by
orchidectomy, local radiotherapy, systemic reinduction and
maintenance chemotherapy.
Non-Hodgkin's lymphoma (NHL) Between 1972 and 1977,
56 consecutive, previously untreated adults were referred with
stage III and IV high grade NHL; they were treated with
OPAL, CNS prophylaxis and maintenance chemotherapy in
a similar manner to patients with ALL, as previously des-
cribed (Lister et al., 1978). In 1986, 12 patients were alive;
seven were available for study. Two patients were lost to
follow-up, one patient refused to be studied, and two patients
were excluded due to a past history of encephalitis and
meningitis respectively. All seven patients studied were well
and in first CR. Their characteristics are presented in Table I.
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Table I Characteristics of patients in study
Non-
ALL Hodgkin's Total
(n = 17) lymphoma (n = 24)
(n = 7)
Presenting age range 15-68 14-57 14-68
(years) median 24 38 27
mean 30.4 36.3 32.1
Male:female 12:5 6:1 18:6
Age at study range 22-77 21 -67 21-77
(years) median 33 49 39
mean 39.8 47.3 42.0
Time elapsed from range 4- 13 8- 12 4-13
CNS prophylaxis- mean 11.7 10.9 11.5
study (years) median 10 11 10
Number in 1st CR 14 7 21
Number in 2nd CR 3 0 3
after extramedullary
relapse
Phenotype Common ALL 10 10
null ALL 5 5
not tested 2 7 9
Examination procedures
Patients underwent five different tests, as described in detail
below. All tests were performed and reported blind by the
individual investigator. Some patients did not undergo every
test due to non availability and/or technical problems. MRI
scans were performed on 19/24 patients. Twenty-two patients
underwent all four remaining tests; one patient did not
undergo neurological or psychometric examinations for logis-
tic reasons, and one further patient failed to attend for
psychometric examination.
Neurological examination A detailed history was taken,
assisted by a questionnaire of 21 points; this was designed to
detect symptoms relating to the central nervous system,
higher cortical functions, cranial nerves, and peripheral ner-
vous system. The patients had a comprehensive physical
examination by a consultant neurologist (J.G.). Each cranial
nerve was individually tested, including visual acuity using a
Snellen chart, visual fields to confrontation using a red 2 mm
target, and hearing using the whispered voice. Attention was
paid to abnormalities of movement, muscle bulk, tone,
power, co-ordination (including speech) and deep tendon
reflexes. Modalities of sensation tested included light touch,
pain, proprioception, vibration sense and stereognosis. Gait
was assessed and Romberg's test performed.
Psychometric examination Patients were first assessed on the
Wechsler Adult Intelligence Scale Revised (WAIS-R) (Wech-
sler, 1981). All verbal tests were administered with the excep-
tion of information and comprehension which is not espec-
ially suitable for British patients, and all the performance
tasks save for object assembly which is somewhat impractical
in the clinic setting. Each patient was assigned a verbal,
performance and full scale IQ score. Patients then took part
in two memory tests, choosing previously shown men's faces
and words (Warrington, 1984). The visual and verbal IQ
scores obtained give information about the non-dominant
and dominant cerebral hemispheres respectively. The max-
imum possible score for each of these memory tests was 50.
Finally each patient underwent the Nelson Adult Reading
Test (NART) in order to establish his or her level of
'pretreatment' functioning, expressed as premorbid IQ. The
maximum possible score using this test is 128. Reading skills
are generally well preserved in the presence of a progressive
dementing illness. In the light of the paediatric data that
performance IQ may be adversely affected with relative spar-
ing of verbal IQ (Meadows et al., 1981; Eiser, 1978), the
difference between these two scores was calculated for each
patient by simple subtraction and designated V-P IQ.
Neurophysiology
Electroencephalogram (EEG) Patients had EEGs performed
in a standard manner in the same room and by the same
technician. Silver silver-chloride stick-on electrodes were app-
lied in standard positions (Pampiglione, 1956; Margerison et
al., 1970). A 14-channel recording was made on a 16-channel
Elema Schonander electroencephalograph with a time con-
stant of 0.3 s and a low pass filter setting of 30 Hz. As well as
the chart recording for visual analysis, the EEG was sampled
on line and stored on magnetic tape for future computer
analysis. The choice of a common average reference montage
and recording procedure was similar to that used in an
earlier study incorporating normal subjects (Binnie et al.,
1978) and thus an age- and sex-matched control was
available from stored data for each patient.
Visual analysis of the paper traces was made by a pair of
observers working separately and blind to non-EEG details,
using a proforma concerned with: (a) background rhythms;
(b) localised abnormality; and (c) generalised abnormality.
Differences in scoring were discussed and resolved by the two
raters. The maximum possible score for the 10 items assessed
by this proforma was 30.
Computer-assisted Fourier analysis was performed. Power
spectra for four conventional and one composite (4-13 Hz)
frequency bands were plotted for each electrode site for
periods with eyes closed and for those with eyes open. Each
frequency spectrum (Figure 4) was characterised by
measurements of power, peak frequency and amplitude, and
seven measures of the shape of the plotted spectrum. The
effects of eye opening and left/right difference were assessed
from these digital data.
Brainstem auditory evoked potentials (BAEP) Click stimuli
at a rate of 16 Hz and an intensity of 90 dB were applied to
the resting patient to each ear in sequence and masking white
noise was presented to the unstimulated ear at 60dB. The
potentials were recorded in a bipolar fashion between the ear
lobe ipsilateral to the ear stimulated and the vertex. A filter
bandpass of 100-3,000 Hz was used and 1,024 signals were
averaged for 10 ms post-stimulus duration. Latencies were
measured from the stimulus to the positive peak of each
wave (conventionally termed I to V) (Stockard et al., 1980)
and left/right latency differences calculated, all measurements
being compared with those from a data base of 19 normal
adults aged 22-46 (mean± 1 s.d. = 28.5±6) years.
Computerised tomography (CT)
Unenhanced CT brain scans were performed with an Interna-
tional General Electric 9000. Scans were performed in theMINIMAL NEUROPSYCHOLOGICAL SEQUELAE 777
horizontal plane at 10 mm contiguous sections. Cerebral sul-
cal width was measured at three sites using a cursor which
yielded results to within 0.1 mm; the maximum width of the
three measurements was selected. Deep cerebral hemisphere
white matter attenuation was determined at three points, and
the mean (in Hounsfield units) was taken as representative.
Magnetic resonance imaging (MRI)
The patients were imaged with an imager using a low field
resistive magnet operating at 0.08T. Four images were
obtained, three in the axial and one in the coronal plane. The
scans were assessed visually on the colour display monitor.
Statistical methods
Data were checked and found not to have normal distribu-
tions; thus comparisions between groups were made by the
Mann-Whitney test for non-parametric data.
Table III Basic psychometric data (n = 22)
IQ
Standard
Item Mean deviation Range Median
Full scale (1) 107 13 84-133 103
Verbal (1) 102 12 83-126 98
Performance (1) 110 14 87- 135 107
Verbal memory (2) 101 24 58-147 100
Visual memory (2) 108 21 59-156 107
'Permorbid' (3) 108 8 89-125 109
Verbal performance - 7 11 13 to -30 -6
Summary of IQs of 22 patients as assessed by: (1) Wechsler Adult
Intelligence Scale-revised; (2) Warrington Recognition Memory Test;
(3) Nelson Adult ReadingTest (maximum possible scoreis 128 with this
test).
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Results
Neurologicalfindings (23 patients)
All patients examined had been fully rehabilitated following
the original diagnosis and treatment, and had returned to
occupational and/or leisure activities. In reply to the ques-
tionnaire persisting symptoms were present in 12 patients
while 11 patients were asymptomatic (Table II). Ten patients
had positive clinical findings and 13 had entirely negative
examinations (Table II). The signs elicited were mostly trivial
(e.g. extensor plantar responses), but corresponded with
symptoms in two patients with unsteadiness and two patients
with hearing loss. The presence of neurological signs was
more likely in patients aged >25 years at the time of CNS
prophylaxis (9/12) than in patients <25 (1/11) (P<0.02).
Psychometricfindings (22 patients)
All patients appeared motivated and co-operative, and were
able to attempt the various tests. Full scale IQ, premorbid IQ
and V-P IQ are summarised in Table III. The mean V-P IQ
for nine patients aged <30 years at the time of testing was
- 12, whereas the mean for 13 patients >30 years was -3.2
(Figure 1). There was thus a trend towards a greater V-P IQ
for younger patients although this just fails to reach statis-
tical significance (P = 0.06). The mean verbal and visual
memory IQs for the five patients who reported forgetfulness
and/or poor concentration in answer to the questionnaire
were 107.5 and 115.5 respectively; these compare favourably
with the entire group of 23 test patients, who had mean
verbal and visual IQs of 100.7 and 107.1 respectively.
Table II Details of symptoms and signs
No. of No. of
Symptoms pts Signs pts
None 11 None 13
Forgetful 5 Abnormal tandem gait 5
Poor concentration 3 Extensor plantar response 3
Unsteady 3 Peripheral sensory loss 3
Poor hearing 3 Romberg's test positive 2
Anxious 2 Hearing loss 2
Headaches 2 Mild pyramidal signs I
Pins and needles 2
Irritable I
Peculiar sense of smell 1
Double vision I
Loss of taste I
Left facial numbness 1
Neurological symptoms and signs by frequency of occurrence in 23
patients. Note that 11 patients had no symptoms, 13 patients had no
signs, andeight patients (35%) had neither symptoms norsigns. Twelve
patients had one or more symptoms, 10 patients had one or more signs.
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Figure I Comparison of difference between verbal and perfor-
mance IQ in patients aged < 30 (n = 9) and patients aged
>30 (n = 13) at the time of testing.
Neurophysiology
EEG (24 patients) Representative EEG traces from a nor-
mal subject and a patient are shown in Figure 2; the latter
has mild abnormality with a slight excess of theta activity
mixed with the alpha rhythm, which is itself somewhat slow,
and is incompletely attenuated on visual attention. It scores
6, while the example from the normal control scores 1. Visual
rating scores for controls and patients were clearly different,
with means of 1.9 and 3.6 respectively (P<0.001). Figure 3
is a frequency histogram of scores for these two groups. The
mean and median visual scores for patients aged <25 years
at CNS prophylaxis were 4.4 and 4 respectively, compared
with 2.8 and 2 for patients aged >25 years, this just failed to
reach statistical significance (P = 0.06).
Examples of averaged autospectra from the same two indi-
viduals' electrodes 02-C4 are shown in Figure 4. They are
derived from the EEG samples in Figure 2; they differ in
height and shape. There were no obvious asymmetries or
localised abnormalities on visual inspection of the EEGs
from the patients. Therefore, the values of the six posterior
electrodes from the computer analysis were averaged for
statistical comparisons. Comparison of patients and controls
showed a significant difference only for the peak frequency
with eyes shut. Despite apparently large differences in the
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Figure 2 Conventional common reference EEG recordings from one patient and the age-matched control subject. The letters and
numbers on the left refer to scalp electrode positions (Pamiglione, 1956; Margerison, 1970), essentially F = frontal, C = central,
T = temporal, 0 = occipital, A = aural regions, TC = time constant, HF = high frequency cut 30% above 30 Hz. Note the higher
voltage monorhythmic 10 Hz alpha rhythm in the normal which attenuates an eye opening, compared with the lower voltage,
poorly responsive, mixed rhythms in the patients (see also Figure 4).
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Figure 3 Histogram of total EEG scores in oncology patients (0) and their age-matched normal controls (M).
mean of some of the other measurements, particularly those
describing the shape of the autospectra, these were not
significant due to the wide scatter of values (Table IV).
Brainstem auditory evoked potentials (BAEPs) (21
patients) Two patients showed marked unilateral abnor-
malities. In one asymptomatic patient this was possibly due
to radiotherapy for subsequent cancer of the tongue. The
second patient developed symptomatic hearing loss of the left
ear of unknown aetiology following his initial treatment for
NHL; he had never received aminoglycoside antibiotics. Five
of 21 patients had an abnormally long wave V/wave I left/
right latency difference, exceeding 0.29 ms (mean for 19 nor-
mal adults ± 2.5 s.d.) (Figure 5).
Computerised tomographY (24 patients)
Sulcal width exceeded 2 mm in 18/24 patients (92%). Eleven
patients aged < 25 years at the time of CNS prophylaxis had
mean sulcal width of 2.2 ±0.5 mm (± 1 s.d.); the value for 13
patients aged >25 years was 2.9±0.8mm (P<0.02). Deep
white matter attenuation lay within the normal range (25-35
Hounsfield units) in all patients.
Magnetic resonance imaging (19 patients)
Scans were performed on 19 patients, 14 with ALL and five
with NHL. These were carefully assessed visually and were
all entirely normal.
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Figure 4 Examples of frequency spectra from the right occipital
region electrode (02) referred to the right central region (C4) in
the subjects whose EEGs are shown in Figure 2. Note the
different scales in the y axis due to the higher voltage alpha
rhythm in the normal subject. Note that the patient not only has
reduced overall EEG power in the 4-13 Hz frequency band, but
that the power is dispersed more widely compared with its con-
centration at 10 Hz in the normal (see Figure 2). This gives a
different shape to the lower part of the spectrum.
Table IV Computer analysis of EEG data
Normals Patients
Power eyes shut (mV2) 310±386 (21) 273± 235 (22)
Power eyes open (mV2) 49± 18 (20) 73±61 (22)
Power difference eyes shut/open 274±386 (20) 200±201 (22)
Peak amplitude (UV) eyes shut 202±308 (20) 134± 146 (22)
Peak frequency (Hz) eyes shut 9.9± 1.2 (21) 9.2±0.8 (22)-
Width high (Hz) eyes shut 1.32± 10.3 (18) 1.65±0.58 (21)
Width low (Hz) eyes shut 2.2±0.85 (18) 3.13±2.1 (21)
Comparison of EEGs from patients and age-matched normal sub-
jects. The items 'width high' and 'width low' refer to the shape ofpower
spectrum (see Figure 4). The reduced n for some items reflects
artefactual (usually patient movement) interference in some sections of
tape recorded data. Values are means ± I s.d. (n). ap<0.05.
I.1.
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Figure 5 Histogram of left/right difference values for auditory
brainstem evoked potential conduction times between auditory-
nerve (wave I) and inferior colliculus (wave V). Normal values
for our laboratory are given (mean ±2.5 s.d.).
Table V Effect of age on examination findings
Presence of Mean EEG
neurological Mean visual Mean cerebral
Age group signs V-P IQ score sulkal width
Younger I - 12 4.4 2.2
Older 9 -4.8 2.8 2.8
P value <0.02 <0.06 <0.06 0.02
The younger group comprises 11 patients who received CNS-P when
they were < 25 years, and the older group comprises the remaining 13
patients. For the analysis ofV-P IQ, the younger group comprises nine
patients aged < 30 years at the time of testing, and the older group
comprises the remaining 15 patients.
cerebral cortical atrophy and presence of neurological signs
were commoner in patients aged >25 years at the time of
CNS treatment (P<0.02 for both correlations).
There was no direct correlation between visual EEG score
and V-P IQ, despite a trend for both a high visual EEG score
and high (more negative) V-P IQ to be commoner in younger
patients. Wave V/wave I left/right latency difference cor-
related weakly with verbal IQ (r = 0.513) and with two
averaged EEG measurements from the six posterior elect-
rodes (r = -0.647, -0.569).
In the light of paediatric data suggesting that proximity of
CNS-P to the start of systemic therapy and the total dose of
intrathecal methotrexate might influence the likelihood of
subsequent problems (Lister et al., 1977; Bleyer, 1981), eight
patients were identified who received less than five doses of
IT methotrexate, and whose cranial irradiation was com-
menced within 10 weeks of diagnosis. They did not differ
significantly in prevalence of neurological signs or symptoms,
V-P IQ, EEG score or cerebral sulcal width when compared
with the remaining 16 patients.
Discussion
Effect ofage on variables
The prevalence of abnormalities, where present, was com-
pared in patients aged <25 years when they received CNS-P
(n = 11) and in those aged >25 years (n = 13). In the case of
V-P IQ, the patients were split into groups <30 years at the
time of testing (n = 9) or >30 years (n = 15). From Table V
it can be seen that the presence of neurological signs and
cerebral atrophy are significantly more common in the older
patients, while there is a trend for V-P IQ and visual EEG
score to be more abnormal in the younger groups.
Correlations between variables
Patients exhibiting neurological signs had significantly wider
cerebral sulci on CT scan than those without (mean +
s.d. 3.1 ±0.9 and 2.3 ±0.5 mm respectively, P<0.05). Both
Although this study deals primarily with potential adverse
effects of treatment it is essential to present them in the
context of its efficacy. From the published results of 112
adults with ALL treated at St Bartholomew's Hospital,
isolated CNS relapse occurred in only three of the 64 patients
(5%) who had entered CR and completed CNS prophylaxis,
showing it to be highly effective (Barnett et al., 1986). It is,
therefore, encouraging that the long-term toxicity of CNS-P
was almost entirely subclinical and trivial, the long-term
survivors of ALL and NHL seen in this study being generally
very well. The majority of patients in this study could not
recall any acute toxicity from CNS prophylaxis. The
incidence of neurological signs, mainly unassociated with
symptoms, was higher in the older patients; similarly CT scan
evidence of cerebral cortical atrophy was commoner in this
group. There was a significant association between cerebral
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cortical atrophy and the presence of neurological signs; both
these findings may well be due to ageing.
The results of a small retrospective study suggest that
intellectual malfunction may be most severe in children
receiving CNS prophylaxis within 2 months of diagnosis
(Eiser, 1978) and in children less than 7 years old (Moss,
1981). The present study has found a trend to a greater V-P
IQ in patients under 25 years at the time of CNS prophylaxis
suggesting that younger adults are more susceptable to
neurotoxicity. The difference approaches statistical
significance (P<0.06) when patients aged <30 at the time
of testing are compared with those aged >30 years. When
inter-group comparisons for presence of CNS signs, cortical
atrophy, and a high EEG score are made using age <30
years and >30 years at testing, rather than <25 years or
>25 years at time of CNS-P, there is no evidence of an
ageing effect; P values rose from <0.02 to 0.07, <0.01 to
0.04, and 0.06 to 0.08 respectively. Only one study to date
has demonstrated a correlation between CT scan abnor-
malities and impaired psychometry (Brouwers et al., 1985);
the present study did not show any relationship, possibly as
the changes in both parameters were small. MRI was
included as it is more sensitive than CT in detecting white
matter disease (Curnes et al., 1986). In the 19 patients
examined no abnormality was detected. Indeed, Tl values lay
towards the lower end of the quoted normal range of
265-292 ms (Kean & Smith, 1986), with no suggestion of the
non-specific prolongation observed by others (Curnes et al.,
1986).
The reporting of EEGs in studies of long-term follow-up
of childhood ALL is notably vague, with no attempt at
quantitation (Moss et al., 1981). In this study a simple
structured visual EEG analysis yielded reproducible and
useful numerical values, and compares favourably with
sophisticated computer analysis in identifying minor abnor-
malities. Abnormalities were all minor; the trend to relatively
more severe abnormalities in the younger group again raises
the possiblity that they have a lower threshold for toxicity, as
with children. As the EEG abnormalities reflect subtle cereb-
ral cortical dysfunction, structural CT changes would not be
expected. Abnormal BAEP latencies in 5/21 patients imp-
licates delayed conduction in the brainstem auditory path-
way, but there was no correlation with age.
In view of the established adverse effects of CNS pro-
phylaxis in childhood ALL, it is reasonable to search for
safer but still effective alternatives (Kean & Smith, 1986;
Nesbit et al., 1981; Bleyer et al., 1985; Chessels, 1985; Komp
et al., 1982; Rowland et al., 1984). Although the number of
patients in the present retrospective study is small, the con-
clusions support the clinical impression that standard CNS-P
in adults is essential, effective and well tolerated, with only
subclinical sequelae, and there is no indication to replace it
until a clearly superior alternative is found.
We thank the staff of the Departments of Medical Oncology,
Radiotherapy and Haematology, and the patients for participating in
the study. Amanda Hewitt and Sian Comber typed the manuscript.
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